FindTrial
Sign In

A study on usage of topical corticosteroids in conditions related to the skin

USe of topical corticostEroids in dermatological conditions: Data from Real-world (USER study) - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060667
Enrollment
1000
Registered
2023-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L208- Other atopic dermatitis

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr Reddys Laboratories Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with =18 years of age diagnosed with psoriasis and prescribed with TCS. Patients diagnosed with atopic dermatitis/eczema and prescribed with TCS.

Exclusion criteria

Exclusion criteria: Patients with incomplete data with respect to study requirements.

Design outcomes

Primary

MeasureTime frame
Usage of TCS in atopic dermatitis/eczema and psoriasis by patient subgroups by age. Prescription pattern of TCS prescribed to patients diagnosed with psoriasis and atopic dermatitis/eczema.Timepoint: this is the study where all endpoints will be assessed baseline. The patients on EMR meeting eligibility criteria from 2017 to 2023 will be evaluated—

Secondary

MeasureTime frame
Comorbid conditions & concomitant medications of patients prescribed with TCS for psoriasis & atopic dermatitis/eczema respectively.Timepoint: this is the study where all endpoints will be assessed baseline. The patients on EMR meeting eligibility criteria from 2017 to 2023 will be evaluated—

Countries

India

Contacts

Public ContactDr Rahul Rathod

Dr Reddys Laboratories Limited

biswajitaich@drreddys.com9864159889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026